What is Sleep Apnea? OSA vs CSA vs Complex Sleep Apnea Explained

Sleep apnea affects 1 billion adults globally (WHO 2023), yet 80% remain undiagnosed. This definitive guide clarifies the critical differences between Obstructive Sleep Apnea (OSA), Central Sleep Apnea (CSA), and Complex Sleep Apnea – complete with diagnostic flowcharts and treatment algorithms validated by sleep physicians.

1. Obstructive Sleep Apnea (OSA): The Collapsed Airway

Pathophysiology

Mechanical Blockage: Throat muscles relax during sleep, causing tongue/base-of-tongue to obstruct the airway.
Key Biomarker: Elevated pharyngeal critical closing pressure (Pcrit > -2 cm H₂O).
Prevalence: 85-90% of all sleep apnea cases.

High-Risk Profiles

Risk factor	OSA Risk Multiplier
BMI ≥30	4.2x
Neck Circumference >17″♂/16″♀	3.8x
Family History	2.9x

2. Central Sleep Apnea (CSA): The Brain Signaling Failure

Mechanism

Neurological Origin: Brainstem fails to send “breathe” signals due to:
- Cheyne-Stokes respiration (heart failure patients)
- Opioid-induced respiratory depression
- High-altitude periodic breathing

Diagnostic Red Flags

Polysomnography Patterns:
- ≥50% apneas are central (no respiratory effort)
- Apnea-Hypopnea Index (AHI) ≥5 with central events dominant

Treatment Alert: CPAP may worsen CSA. First-line therapy = Adaptive Servo-Ventilation (ASV).

3. Complex Sleep Apnea: The Hybrid Threat

Definition

Emerges During CPAP Therapy: OSA patients develop new central apneas after starting CPAP (15-20% incidence).
Pathogenesis: Overventilation-induced CO₂ lowering disrupts respiratory drive.

Management Protocol

Confirm via split-night sleep study during CPAP titration.
Switch to ASV or BiPAP with backup rate.
Re-evaluate after 3 months (40% resolve spontaneously).

4. Differential Diagnosis: Flowchart for Clinicians

5. Evidence-Based Treatments Compared

Therapy	OSA Efficacy	CSA Efficacy	Complex Efficacy
CPAP	89% AHI reduction	22% worsening	Contraindicated
ASV	Off-label	76% AHI reduction	81% AHI reduction
Phrenic Nerve Stim	N/A	FDA-approved	Under trial
Oxygen Therapy	Adjuvant only	34% improvement	Case-dependent

Data Sources: SERVE-HF Trial (2015), ADVENT-HF Trial (2023), AASM Guidelines.

6. Patient Action Plan

Suspected Sleep Apnea?
- Take the STOP-BANG Self-Test
- Record snoring episodes via smartphone apps (e.g., SnoreLab)
Diagnosed with CSA/Complex?
- Demand in-lab PSG with CO₂ monitoring
- Consult a cardiologist if Cheyne-Stokes suspected
Therapy Adherence Tips:
- Use CPAP data apps (ResMed myAir) to track central vs obstructive events
- Join CSA-specific support groups

Browse